Senté Strengthens Commitment to Dermatology with Gallo Partnership Renewal
Senté, a California-based medical-grade skincare company, has officially renewed its collaboration with Dr. Richard Gallo as the Chief Scientific Advisor. This announcement, made on June 4, 2026, signifies a continued commitment to advancing innovative skincare solutions rooted in robust scientific research. Dr. Gallo, who is widely recognized for his expertise in dermatology and skin biology, has been instrumental in shaping Senté's scientific framework and clinical trajectory since the company's inception.
Dr. Gallo, a prominent figure in dermatological research, has steered the development of Senté's patented Heparan Sulfate Analog (HSA) technology. This groundbreaking technology plays a pivotal role in enhancing skin repair and rejuvenation. By replenishing Heparan Sulfate—an essential molecule in maintaining healthy skin—the technology supports the restoration of biological functions necessary for skin resilience, cellular communication, and efficient repair processes.
The extension of Dr. Gallo’s advisory role will enable him to continue guiding Senté on clinical research projects, product development pathways, and overarching scientific strategies. The renewal is aimed at fortifying Senté's standing in the competitive skincare market by focusing on next-generation solutions informed by regenerative skin science. Zubin Meshginpoosh, President and CEO of Senté, emphasized that Dr. Gallo’s contributions have been foundational to the essence of the company, aiding in the validation of its innovative HSA technology.
In a statement, Dr. Gallo expressed his pride in continuing his partnership with Senté, highlighting the brand’s dedication to rigorously developed skincare solutions. He acknowledged Senté's commitment to evidence-based product development as a key differentiator in the professional skincare arena.
Dr. Gallo is not only a driving force at Senté; he is also recognized globally for his extensive research in skin immunology, defenses, and overall dermatological health. Currently serving as the Distinguished Professor and Founding Chair of the Department of Dermatology at the University of California San Diego, his academic credentials add significant prestige to Senté's scientific advisory team.
Senté's signature HSA technology has been meticulously designed to support skin functions by not only steering the recovery processes but also by reducing visible signs of aging and inflammation. The company's approach underscores the belief that scientific innovation is the cornerstone of effective skincare. Senté seeks to pioneer regenerative skincare through its biomimetic science, delivering formulations that are gentle, well-tolerated, and suitable for sensitive skin, making the products accessible to a broader customer base.
The company prides itself on its commitment to scientific rigor while ensuring that its research and products are vetted by medical professionals. Senté’s founding principle of putting science above trends remains central to its operations, allowing it to differentiate itself within the ever-evolving skincare sector.
In summary, the renewal of the partnership with Dr. Gallo not only reflects Senté's commitment to sustainable and scientifically validated skincare but also cements its position as a leader in dermatological innovations. As the skincare market continues to expand and evolve, Senté stands poised to offer cutting-edge solutions driven by a deep-rooted belief in the power of scientific research and clinical validation.
Dr. Gallo, a prominent figure in dermatological research, has steered the development of Senté's patented Heparan Sulfate Analog (HSA) technology. This groundbreaking technology plays a pivotal role in enhancing skin repair and rejuvenation. By replenishing Heparan Sulfate—an essential molecule in maintaining healthy skin—the technology supports the restoration of biological functions necessary for skin resilience, cellular communication, and efficient repair processes.
The extension of Dr. Gallo’s advisory role will enable him to continue guiding Senté on clinical research projects, product development pathways, and overarching scientific strategies. The renewal is aimed at fortifying Senté's standing in the competitive skincare market by focusing on next-generation solutions informed by regenerative skin science. Zubin Meshginpoosh, President and CEO of Senté, emphasized that Dr. Gallo’s contributions have been foundational to the essence of the company, aiding in the validation of its innovative HSA technology.
In a statement, Dr. Gallo expressed his pride in continuing his partnership with Senté, highlighting the brand’s dedication to rigorously developed skincare solutions. He acknowledged Senté's commitment to evidence-based product development as a key differentiator in the professional skincare arena.
Dr. Gallo is not only a driving force at Senté; he is also recognized globally for his extensive research in skin immunology, defenses, and overall dermatological health. Currently serving as the Distinguished Professor and Founding Chair of the Department of Dermatology at the University of California San Diego, his academic credentials add significant prestige to Senté's scientific advisory team.
Senté's signature HSA technology has been meticulously designed to support skin functions by not only steering the recovery processes but also by reducing visible signs of aging and inflammation. The company's approach underscores the belief that scientific innovation is the cornerstone of effective skincare. Senté seeks to pioneer regenerative skincare through its biomimetic science, delivering formulations that are gentle, well-tolerated, and suitable for sensitive skin, making the products accessible to a broader customer base.
The company prides itself on its commitment to scientific rigor while ensuring that its research and products are vetted by medical professionals. Senté’s founding principle of putting science above trends remains central to its operations, allowing it to differentiate itself within the ever-evolving skincare sector.
In summary, the renewal of the partnership with Dr. Gallo not only reflects Senté's commitment to sustainable and scientifically validated skincare but also cements its position as a leader in dermatological innovations. As the skincare market continues to expand and evolve, Senté stands poised to offer cutting-edge solutions driven by a deep-rooted belief in the power of scientific research and clinical validation.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.